Seno Medical Instruments, Inc.

Jan 08, 2019

Multiple Publications and Presentations Underscore Seno Medical's Value Proposition in Mitigating the Cost and Burden of Unnecessary Breast Biopsies

May 31, 2018

Annual Cost of False-Positive Breast Biopsies Exceeds $2 Billion According to Recent Study

May 03, 2018

New Analytics Approach Offers Potential of Reducing Unnecessary Breast Biopsies

Jan 30, 2018

Opto-Acoustic Imaging Leader Seno Medical Instruments Announces Recipient of Its 8th Annual Best Paper Award during the SPIE Annual Conference

Dec 08, 2017

Seno Medical Instruments Announces New Data Demonstrating That Imagio(TM) Opto-Acoustic Breast Imaging System Delivers Critical Diagnostic and Prognostic Information About Tumor Subtypes

Nov 28, 2017

Seno Medical Instruments' Imagio(TM) Opto-Acoustic Breast Imaging System Demonstrates Ability to Downgrade Risk Classification of Benign Breast Masses in a Prospective European Clinical Trial

Nov 27, 2017

Pivotal Trial Data Support Potential of Seno Medical Instruments' Imagio(TM) Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies